Baloxavir Marboxil
Overview
Baloxavir Marboxil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297503).
API suppliers (6)
Suppliers of Baloxavir Marboxil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 6 suppliers.
2 of 6 hold a GMP certificate on record in the EU or UK registers
- SUZHOU RYWAY BIOTECH CO LTD1 active DMF
- CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Porton Pharma Solutions Ltd.China1 active DMF
- SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTDChina1 active DMF
- Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.China1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (7 approved US products), the latest listed US patent on Baloxavir Marboxil expires 21 Apr 2041 and exclusivity 19 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-yl]oxymethyl methyl carbonate
- Canonical SMILES
- COC(=O)OCOC1=C2C(=O)N3CCOC[C@H]3N(N2C=CC1=O)[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F
- InChIKey
- RZVPBGBYGMDSBG-GGAORHGYSA-N
Do you supply Baloxavir Marboxil? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.